<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">  
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2024.1382896</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Unveiling the molecular complexity of proliferative diabetic retinopathy through scRNA-seq, AlphaFold 2, and machine learning</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wang</surname>
<given-names>Jun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1218808"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Sun</surname>
<given-names>Hongyan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1218729"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mou</surname>
<given-names>Lisha</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1199233"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Ying</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1567428"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Zijing</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Pu</surname>
<given-names>Zuhui</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1502626"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yang</surname>
<given-names>Ming-ming</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Endocrinology, Shenzhen People&#x2019;s Hospital (The Second Clinical Medical College of Jinan University; The First Affiliated Hospital, Southern University of Science and Technology)</institution>, <addr-line>Shenzhen</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Ophthalmology, Shenzhen People&#x2019;s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology)</institution>, <addr-line>Shenzhen</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Imaging Department, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People&#x2019;s Hospital</institution>, <addr-line>Shenzhen</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>MetaLife Center, Shenzhen Institute of Translational Medicine</institution>, <addr-line>Guangdong, Shenzhen</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Mohd Imtiaz Nawaz, King Saud University, Saudi Arabia</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Yinan Jiang, University of Pittsburgh, United States</p>
<p>Ioannis Serafimidis, Biomedical Research Foundation of the Academy of Athens (BRFAA), Greece</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Ming-ming Yang, <email xlink:href="mailto:ming4622@163.com">ming4622@163.com</email>; Zuhui Pu, <email xlink:href="mailto:zuhuipu@email.szu.edu.cn">zuhuipu@email.szu.edu.cn</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>05</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1382896</elocation-id>
<history>
<date date-type="received">
<day>06</day>
<month>02</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>04</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Wang, Sun, Mou, Lu, Wu, Pu and Yang</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Wang, Sun, Mou, Lu, Wu, Pu and Yang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Proliferative diabetic retinopathy (PDR), a major cause of blindness, is characterized by complex pathogenesis. This study integrates single-cell RNA sequencing (scRNA-seq), Non-negative Matrix Factorization (NMF), machine learning, and AlphaFold 2 methods to explore the molecular level of PDR.</p>
</sec>
<sec>
<title>Methods</title>
<p>We analyzed scRNA-seq data from PDR patients and healthy controls to identify distinct cellular subtypes and gene expression patterns. NMF was used to define specific transcriptional programs in PDR. The oxidative stress-related genes (ORGs) identified within Meta-Program 1 were utilized to construct a predictive model using twelve machine learning algorithms. Furthermore, we employed AlphaFold 2 for the prediction of protein structures, complementing this with molecular docking to validate the structural foundation of potential therapeutic targets. We also analyzed protein&#x2212;protein interaction (PPI) networks and the interplay among key ORGs.</p>
</sec>
<sec>
<title>Results</title>
<p>Our scRNA-seq analysis revealed five major cell types and 14 subcell types in PDR patients, with significant differences in gene expression compared to those in controls. We identified three key meta-programs underscoring the role of microglia in the pathogenesis of PDR. Three critical ORGs (ALKBH1, PSIP1, and ATP13A2) were identified, with the best-performing predictive model demonstrating high accuracy (AUC of 0.989 in the training cohort and 0.833 in the validation cohort). Moreover, AlphaFold 2 predictions combined with molecular docking revealed that resveratrol has a strong affinity for ALKBH1, indicating its potential as a targeted therapeutic agent. PPI network analysis, revealed a complex network of interactions among the hub ORGs and other genes, suggesting a collective role in PDR pathogenesis.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>This study provides insights into the cellular and molecular aspects of PDR, identifying potential biomarkers and therapeutic targets using advanced technological approaches.</p>
</sec>
</abstract>
<kwd-group>
<kwd>diabetic retinopathy</kwd>
<kwd>single-cell analysis</kwd>
<kwd>oxidative stress</kwd>
<kwd>AlphaFold 2</kwd>
<kwd>NMF</kwd>
<kwd>PPI</kwd>
<kwd>machine learning</kwd>
<kwd>ALKBH1</kwd>
</kwd-group>
<counts>
<fig-count count="7"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="36"/>
<page-count count="12"/>
<word-count count="4534"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Clinical Diabetes</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Proliferative diabetic retinopathy (PDR), an advanced stage of diabetic retinopathy, is a leading cause of irreversible blindness in the productive-age population worldwide (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). Characterized by retinal neovascularization leading to severe complications such as neovascular glaucoma, vitreous hemorrhage, and retinal detachment, the pathogenesis of PDR has not been fully elucidated (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). Despite recent advances in imaging and management (<xref ref-type="bibr" rid="B5">5</xref>), understanding the underlying molecular mechanisms is crucial for developing effective therapies.</p>
<p>Oxidative stress, which is notably exacerbated in diabetes, plays a pivotal role in PDR pathogenesis (<xref ref-type="bibr" rid="B6">6</xref>). It damages mitochondrial structures and DNA in the retinal vasculature, impairing cellular function (<xref ref-type="bibr" rid="B7">7</xref>). This stress is a key contributor to neovascular unit insults, underpinning the core pathophysiology of PDR. Additionally, diabetic patients are more susceptible to oxidative stress due to impaired defense mechanisms, further emphasizing the role of oxidative stress in the development and progression of diabetic retinopathy, including PDR (<xref ref-type="bibr" rid="B8">8</xref>).</p>
<p>Single-cell RNA sequencing (scRNA-seq) has significantly advanced disease research by providing detailed insights into the cellular and molecular dimensions of various diseases (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>). Its ability to dissect gene expression at the individual cell level reveals the intricate cellular landscape of PDR, distinguishing between diseased and healthy states (<xref ref-type="bibr" rid="B11">11</xref>). The study carried out by Hu et&#xa0;al. provides valuable insights into the use of scRNA-seq in studying PDR (<xref ref-type="bibr" rid="B12">12</xref>). These authors highlighted the application of scRNA-seq for gene expression profiling, identifying cell populations in fibrovascular membranes from PDR patients, and revealing the novel role of microglia in the fibrovascular membrane of PDR. These studies collectively emphasize the significance of scRNA-seq in unraveling the molecular and cellular complexities of PDR, offering a promising approach for further research and potential therapeutic interventions.</p>
<p>Concurrently, the integration of machine learning algorithms, particularly in predictive modeling, has introduced a new dimension to biomedical research (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>). These algorithms, including LASSO, Ridge, and Elastic Net, facilitate the development of predictive models for PDR, thereby increasing the accuracy of diagnoses and informing personalized treatment approaches.</p>
<p>In our study, we combined single-cell sequencing with advanced machine learning methods, as well as Non-negative Matrix Factorization (NMF), to uncover transcriptional and oxidative stress signatures in PDR. Our goal was to pinpoint oxidative stress-related genes (ORGs) that could serve as biomarkers, aiming to enhance the diagnostic and therapeutic landscape of PDR.</p>
</sec>
<sec id="s2">
<title>Methods</title>
<sec id="s2_1">
<title>Data processing</title>
<p>ScRNA-seq data from five proliferative diabetic retinopathy (PDR) patients (GSE165784) (<xref ref-type="bibr" rid="B12">12</xref>) and three control samples (<xref ref-type="bibr" rid="B15">15</xref>) were processed alongside two bulk RNA PDR patient cohorts from the GEO database (cohort 1: GSE160306 (<xref ref-type="bibr" rid="B16">16</xref>), 76 samples; cohort 2: GSE102485 (<xref ref-type="bibr" rid="B17">17</xref>), 25 samples). Oxidative stress-related genes (ORGs) were identified from the Gene Ontology and PathCards databases.</p>
</sec>
<sec id="s2_2">
<title>Single-cell data analysis of PDR patients</title>
<p>The single-cell data of five PDR patients (<xref ref-type="bibr" rid="B12">12</xref>) and three healthy controls (<xref ref-type="bibr" rid="B15">15</xref>) were analyzed via Seurat (<xref ref-type="bibr" rid="B18">18</xref>). We filtered cells based on mitochondrial content (&lt;10%), cell count (&gt;300), and gene number (1000-5000). The t-distributed stochastic neighbor embedding (t-SNE) (<xref ref-type="bibr" rid="B19">19</xref>) and &#x2018;RunHarmony&#x2019; functions (<xref ref-type="bibr" rid="B20">20</xref>) facilitated visualization and batch effect correction. Cell subtypes were annotated according to cell markers from the original study (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B15">15</xref>). In the differential expression analysis between microglia and mesenchymal cells in PDR versus control samples, the mitochondrial and ribosomal genes were removed. We used the Wilcoxon signed-rank test to identify significant genes (adjusted P value &lt;0.05, absolute log<sub>2</sub>FC &gt;1).</p>
</sec>
<sec id="s2_3">
<title>Non-negative matrix factorization and meta-program detection of microglia in PDR patients</title>
<p>NMF analysis, specifically consensus NMF (cNMF), was applied to microglia in PDR samples, standardizing negative values to zero. After more than 100 iterations, we explored the components (k) ranging from 2 to 10 signatures, determining the optimal component number via a diagnostic plot from the provided tutorial (<ext-link ext-link-type="uri" xlink:href="https://github.com/dylkot/cNMF">https://github.com/dylkot/cNMF</ext-link>) (<xref ref-type="bibr" rid="B21">21</xref>). A two-step gene ranking algorithm was used to identify nonoverlapping gene modules, which were further analyzed for expression patterns using Pearson correlations and hierarchical clustering, revealing three distinct meta-programs.</p>
</sec>
<sec id="s2_4">
<title>Establishment of a machine learning-driven predictive ORG model for PDR patients</title>
<p>Twelve machine learning algorithms, including (1) Least Absolute Shrinkage and Selection Operator (LASSO), (2) Ridge, (3) Elastic network (Enet), (4) Stepglm, (5) Support Vector Machines (SVM), (6) GlmBoost, (7) Linear Discriminant Analysis (LDA), (8) Partial Least Squares Regression for Generalized Linear Models (plsRglm), (9) Random Forest (RSF), (10) Generalized Boosted Regression Models (GBMs), (11) XGBoost, (12) Naive Bayes, were utilized to develop a predictive ORG model for PDR. We constructed 109 model combinations, trained initial models with the GSE160306 cohort and validated them with the GSE102485 cohort. Model performance was assessed using the AUC.</p>
</sec>
<sec id="s2_5">
<title>Prediction of the structure of proteins</title>
<p>We utilized AlphaFold 2, a tool that has achieved remarkably accurate levels comparable to those obtained through human observation via advanced techniques such as cryoelectron microscopy, for the prediction of protein structures (<xref ref-type="bibr" rid="B22">22</xref>). For our specific study objectives, we used AlphaFold 2 to predict the structures of select proteins relevant to our research. We focused on the proteins ALKBH1, PSIP1, and ATP13A2, which play significant roles in the context of PDR. The sequences of these proteins were meticulously retrieved from the NCBI database (<xref ref-type="bibr" rid="B23">23</xref>).</p>
</sec>
<sec id="s2_6">
<title>Molecular docking analysis</title>
<p>To investigate the binding affinities and interaction patterns of the drug candidates with their targets, we utilized AutoDock Vina 1.2.2, a software designed for in silico protein&#x2013;ligand docking (<xref ref-type="bibr" rid="B24">24</xref>). The molecular structure of resveratrol was obtained from the PubChem Compound database (<ext-link ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov/">https://pubchem.ncbi.nlm.nih.gov/</ext-link>) (<xref ref-type="bibr" rid="B25">25</xref>). AlphaFold 2 was used to generate the 3D coordinates for ALKBH1. Before docking analysis, all proteins and ligand files were prepared by converting them into PDBQT format. This preparation involved the removal of water molecules and the addition of polar hydrogen atoms to ensure accurate docking simulations. The docking grid box was strategically positioned to encompass the target protein&#x2019;s domain, allowing for unhindered molecular movement within the simulation. The dimensions of the grid box were set to 30 &#xc5; &#xd7; 30 &#xc5; &#xd7; 30 &#xc5;, with a grid point spacing of 0.05 nm to capture detailed interaction data. The molecular docking studies were conducted using AutoDock Vina 1.2.2 (<ext-link ext-link-type="uri" xlink:href="http://autodock.scripps.edu/">http://autodock.scripps.edu/</ext-link>).</p>
</sec>
<sec id="s2_7">
<title>Protein interaction network analysis of key ORGs</title>
<p>In our study, we investigated protein interactions involving three pivotal ORGs. The use of the STRING database (<ext-link ext-link-type="uri" xlink:href="https://string-db.org/">https://string-db.org/</ext-link>) (<xref ref-type="bibr" rid="B26">26</xref>), a comprehensive resource, enabled us to compile and amalgamate data on protein&#x2212;protein interactions (PPIs). Our focus was directed toward interactions with confidence scores surpassing 0.7, a threshold set to ensure the biological relevance and significance of these interactions.</p>
<p>To deepen our analysis and improve its visualization, we transferred the relevant data into Cytoscape (version 3.8.2) (<xref ref-type="bibr" rid="B27">27</xref>). Within the Cytoscape environment, we leveraged the capabilities of the cytoHubba plugin. This allowed us to pinpoint and rank the top 10 nodes in the PPI network. The ranking process utilized seven distinct algorithms, each contributing a unique perspective to the analysis. These algorithms included the following: Radiality, which measures the centrality of a node; Maximum Neighborhood Component (MNC), which assesses the largest connected component around a node; Maximum Clique Centrality (MCC), which focuses on the largest clique a node belongs to; Edge Percolated Component (EPC), which evaluates the connectivity and clustering; DMNC, which is the Maximum Neighborhood Component Centrality, a derivative of the MNC; Degree, which counts the number of edges linked to a node; and Closeness, which measures the average distance to other nodes. To synthesize and present our findings, we utilized an UpSet diagram.</p>
</sec>
<sec id="s2_8">
<title>Identification of hub genes associated with PDR</title>
<p>To identify the hub genes associated with PDR, we used the Comparative Toxicogenomics Database (CTD, <ext-link ext-link-type="uri" xlink:href="http://ctdbase.org/">http://ctdbase.org/</ext-link>) (<xref ref-type="bibr" rid="B28">28</xref>). Utilizing the CTD, we conducted an in-depth analysis to unravel the connections between potential key genes and a spectrum of relevant conditions. This included not only PDR but also a broader scope of related health issues, such as other eye diseases, retinal disorders, vascular diseases, complications arising from diabetes, and diabetes mellitus itself.</p>
</sec>
<sec id="s2_9">
<title>Statistical analysis</title>
<p>All the statistical analyses of single cells were performed with R (version 4.3.1). A <italic>P</italic> value less than 0.05 was considered to indicate statistical significance if not explicitly stated.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Analysis of single-cell RNA sequencing data</title>
<p>In this study, we conducted an in-depth analysis of single-cell RNA sequencing data from five patients with proliferative diabetic retinopathy (PDR) (GSE165784) (<xref ref-type="bibr" rid="B12">12</xref>) and three healthy controls (<xref ref-type="bibr" rid="B15">15</xref>), implementing t-distributed stochastic neighbor embedding (t-SNE) for visualization post-quality control and data normalization. This approach effectively distinguished between cellular clusters of the PDR and control cohorts.</p>
<p>
<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref> displays the range and individual RNA counts per cell, reflecting successful quality control measures for our sample analysis. We highlighted the 2000 genes with the highest variability across samples in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>. To further dissect this complexity, we applied linear dimensionality reduction to compute principal components (PCs), as illustrated in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>. The determination of significant PCs was aided by the integration of both ElbowPlot (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>) and JackStrawPlot (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1E</bold>
</xref>), setting the stage for more nuanced analyses. The distribution of cells across the PDR and control groups is presented in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1F</bold>
</xref>, with the study encompassing 5 PDR and 3 control samples, as depicted in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1G</bold>
</xref>. A total of 26 clusters were identified across the samples (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1H</bold>
</xref>). Through marker analysis from the original study (<xref ref-type="bibr" rid="B12">12</xref>), we classified cells into five primary types: microglia, lymphocytes, myeloid cells, endothelial cells, and mesenchymal cells (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1I</bold>
</xref>). This categorization was further refined, resulting in the identification of 14 distinct subcell types (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1J</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Single-cell RNA sequencing analysis of proliferative diabetic retinopathy (PDR) samples compared with normal samples. <bold>(A)</bold> Quality control of single-cell RNA sequencing data for PDR and normal samples. <bold>(B)</bold> Identification of highly variable genes. The top 2000 variable genes are shown as red dots. <bold>(C)</bold> Principal component analysis. Accordingly, we classified the cell groups into two categories. ElbowPlot <bold>(D)</bold> and JackStrawPlot <bold>(E)</bold> of principal components. T-distributed stochastic neighbor embedding (t-SNE) analysis of different groups <bold>(F)</bold>, 8 samples <bold>(G)</bold>, 26 clusters <bold>(H)</bold>, five major cell types <bold>(I)</bold>, and 14 subcell types <bold>(J)</bold>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1382896-g001.tif"/>
</fig>
</sec>
<sec id="s3_2">
<title>Analysis of gene expression variations and cell-cell interactions in PDR</title>
<p>Our investigation of differential gene expression and intercellular communication within the retinal microenvironment of PDR patients highlighted important findings. We observed pronounced ligand-receptor interactions among various cell types, with notable interactions between microglia and mesenchymal cells, as well as between microglia and endothelial cells (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2A, B</bold>
</xref>). These interactions shed light on the intricate signaling pathways that could be instrumental in the development and progression of PDR, suggesting potential therapeutic targets.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Detailed analysis of cell-cell communication and gene expression in PDR. <bold>(A, B)</bold> Cell-cell communication network maps for five major cell types based on the number of involved genes <bold>(A)</bold> and interaction weights/strengths <bold>(B)</bold>. <bold>(C&#x2013;F)</bold> Gene expression analysis of microglia and mesenchymal cells. Upregulated <bold>(C)</bold> and downregulated <bold>(D)</bold> genes in both cell types. <bold>(E)</bold> Downregulated genes in mesenchymal cells but upregulated genes in microglia. <bold>(F)</bold> Upregulated genes in mesenchymal cells but downregulated genes in microglia.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1382896-g002.tif"/>
</fig>
<p>In a detailed analysis of gene expression between microglia and mesenchymal cells in PDR versus control samples, 40 genes were upregulated, and 111 genes were downregulated in both cell types (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2C, D</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Tables&#xa0;1</bold>
</xref>&#x2013;<xref ref-type="supplementary-material" rid="SM4">
<bold>4</bold>
</xref>). The upregulated genes, including FN1, ATP5F1E, B2M, MALAT1, and ATP5MG, and downregulated genes, such as ATP5E, ALDOA, ATP5L, ATP5I, and C14orf2, indicate a complex regulatory landscape. Furthermore, we revealed nuanced gene expression patterns: GLUL, DAB2, SELENOP, and ALDH1A1 were downregulated in mesenchymal cells but upregulated in microglia (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2E</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM5">
<bold>Supplementary Tables&#xa0;5</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM6">
<bold>6</bold>
</xref>), while C12orf75, ITM2C, and CCND1 showed the opposite pattern (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2F</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM7">
<bold>Supplementary Tables&#xa0;7</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM8">
<bold>8</bold>
</xref>).</p>
</sec>
<sec id="s3_3">
<title>Identification of transcriptional programs in PDR microglia cells using non-negative matrix factorization</title>
<p>In our detailed investigation of specific microglia within PDR samples, we employed the sophisticated technique of NMF to determine the unique transcriptional landscape of these cells. This advanced approach allowed us to systematically catalog various gene modules, which are fundamentally crucial in defining the distinct states of cells. Through this meticulous process, we were able to identify and analyze patterns of gene coexpression within individual PDR samples.</p>
<p>Our comparative analysis across multiple PDR samples was instrumental in revealing recurring gene modules. This aspect of our study was particularly significant because it effectively minimized the impact of technical variations, thereby enhancing the reliability and accuracy of our findings. By focusing on these gene modules, we gained valuable insights into the transcriptional intricacies inherent in PDR microglia.</p>
<p>One of the most noteworthy outcomes of our analysis was the identification of three distinct meta-programs. These meta-programs were discerned and clustered based on their correlation coefficients, providing a clear representation of the transcriptional synergy within microglia. The top-scoring genes of these meta-programs were characterized, as depicted in <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>. Notably, Meta-Program 1 emerged as particularly prominent, exhibiting the highest level of correlation among the three. These results suggest that the genes within Meta-Program 1 are potentially central to the transcriptional identity and function of microglia in the context of PDR.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Catalog of PDR gene modules in microglia. <bold>(A)</bold> Heatmap demonstrating the significance of the overlap between PDR gene modules in microglia, identifying three consensus modules: Meta-Program 1, Meta-Program 2, and Meta-Program 3. <bold>(B)</bold> Identification of 15 genes at the intersection of Meta-Program 1 and oxidative stress-related genes (ORGs) from the Gene Ontology and PathCards databases.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1382896-g003.tif"/>
</fig>
<p>Elucidation of these meta-programs is important to our understanding of PDR. This study provides a novel perspective on the transcriptional dynamics of microglia, a critical component of disease pathology. This insight not only enhances our understanding of the molecular mechanisms underlying PDR but also opens up new directions for targeted therapeutic strategies aimed at modulating these specific transcriptional programs.</p>
</sec>
<sec id="s3_4">
<title>Development and validation of the oxidative stress-related gene predictive model for PDR</title>
<p>To develop a predictive model for PDR based on ORGs, we examined a subset of 15 genes that notably intersected within Meta-Program 1, as illustrated in <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>. We constructed ORG models by twelve diverse machine learning algorithms, including (1) Least Absolute Shrinkage and Selection Operator (LASSO), (2) Ridge, (3) Elastic network (Enet), (4) Stepglm, (5) Support Vector Machines (SVM), (6) GlmBoost, (7) Linear Discriminant Analysis (LDA), (8) Partial Least Squares Regression for Generalized Linear Models (plsRglm), (9) Random Forest (RSF), (10) Generalized Boosted Regression Models (GBMs), (11) XGBoost, (12) Naive Bayes (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). Among the 109 models constructed, the cream of the crop emerged in the form of models based on a sophisticated Stepglm [backward]+RF approach. These standout models prominently featured three key ORGs, ALKBH1, PSIP1, and ATP13A2, as delineated in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>. The importance of this model was unmistakably demonstrated in the training cohort (GSE160306), in which an outstanding area under the curve (AUC) of 0.989 was achieved. This exceptional level of predictive accuracy underlines the model&#x2019;s formidable potential as a tool for diagnosing PDR.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Development of machine learning-derived predictive models. <bold>(A)</bold> AUC results for combinations of machine learning algorithms in the training and validation cohorts. The training cohort was GSE160306, and the validation cohort was GSE102485. <bold>(B)</bold> Description of the three hub ORGs included in the highest-performing model. <bold>(C)</bold> Protein structures of three hub ORGs predicted using AlphaFold 2.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1382896-g004.tif"/>
</fig>
<p>To further validate the model&#x2019;s applicability in a clinical setting, we undertook a validation study using an external cohort (GSE102485). The results were encouraging, as the model retained a significant level of diagnostic accuracy, as evidenced by an AUC of 0.833. This performance in an external cohort not only reinforces the model&#x2019;s robustness but also underscores its potential utility as an early detection and ongoing monitoring tool for PDR.</p>
</sec>
<sec id="s3_5">
<title>Structural prediction and molecular docking analysis</title>
<p>In our study, we harnessed the ability of AlphaFold 2 technology to predict the complex structures of three pivotal ORGs, ALKBH1, PSIP1, and ATP13A2, as shown in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>. The predictive confidence for ALKBH1 and ATP13A2 was notably high, whereas PSIP1 demonstrated lower confidence levels and was subsequently not included in further analysis.</p>
<p>Furthermore, to assess the binding affinity of potential therapeutic agents for these targets, we conducted a molecular docking analysis. Specifically, we explored the interaction between ALKBH1 and the candidate drug resveratrol utilizing AutoDock Vina v.1.1.2 for this purpose. The analysis provided insights into the binding modes and calculated the binding energies for the interactions (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5A&#x2013;C</bold>
</xref>). The derived binding energy for the ALKBH1-resveratrol complex was -6.471 kcal/mol, suggesting a highly stable interaction. This strong and stable binding affinity further underscores the potential therapeutic relevance of targeting ALKBH1 with resveratrol in the context of oxidative stress-related conditions.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Molecular docking of resveratrol with ALKBH1. <bold>(A)</bold> Three-dimensional configuration of the ALKBH1 protein. <bold>(B)</bold> Illustration of the binding interaction between the ALKBH1 protein and resveratrol. <bold>(C)</bold> A closer view of the molecular docking of resveratrol with ALKBH1, highlighting local amplification details.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1382896-g005.tif"/>
</fig>
</sec>
<sec id="s3_6">
<title>Protein interaction analysis of key ORGs in PDR</title>
<p>Next, we explored the protein-protein interactions (PPIs) of these ORGs. For this purpose, we utilized the STRING database, which is renowned for its extensive protein interaction data. Our focus was on interactions with confidence scores exceeding 0.7, ensuring that only biologically significant and reliable interactions were considered. This selective approach was instrumental in sifting through vast data to identify meaningful connections that could be crucial in the context of PDR.</p>
<p>The PPI network enriched with these curated data was then intricately analyzed using Cytoscape. This platform enabled us to visualize and dissect the complex web of interactions. Using the cytoHubba plugin within Cytoscape, we systematically identified the top 10 nodes in the network utilizing a suite of seven sophisticated algorithms. These included Radiality, Maximum Neighborhood Component (MNC), Maximum Clique Centrality (MCC), EPC (Edge Percolated Component), DMNC (Maximum Neighborhood Component Centrality), Degree, and Closeness, each offering a unique lens to view and understand the network&#x2019;s structure. <xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6A, B</bold>
</xref> depict these findings, revealing a comprehensive map of the interactions.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Construction of the protein-protein interaction (PPI) network and functional enrichment analysis of the three hub ORGs. <bold>(A)</bold> The PPI network was constructed based on 50 genes closely related to the three hub ORGs. <bold>(B)</bold> The top ten hub genes in the PPI network were identified using seven analytical algorithms. <bold>(C)</bold> UpSet plot displaying overlapping genes identified by all algorithms.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1382896-g006.tif"/>
</fig>
<p>Furthermore, to emphasize the interconnected nature of these interactions, we constructed an UpSet diagram (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>). This visualization succinctly highlighted the convergence of hub genes across different algorithms, revealing key proteins such as H2AC8, H2BC12, H2AC13, and H2AC16 that were consistently central across all algorithms, as detailed in <xref ref-type="supplementary-material" rid="SM9">
<bold>Supplementary Table&#xa0;9</bold>
</xref>. This representation was instrumental in highlighting the core genes within the network, thereby elucidating their potential collective role in the pathophysiology of PDR.</p>
</sec>
<sec id="s3_7">
<title>Integrating comparative toxicogenomics database analysis with PDR research</title>
<p>To complement our protein interaction analysis, we utilized CTD as an instrumental resource. The CTD facilitated the expansion of our study to investigate the connections between our identified hub ORGs and a range of conditions associated with PDR, such as diabetic retinopathy, various eye and retinal diseases, vascular complications, and diabetes mellitus itself. <xref ref-type="fig" rid="f7">
<bold>Figures&#xa0;7A&#x2013;F</bold>
</xref> display these connections, emphasizing the marked correlation between genes ALKBH1, PSIP1, ATP13A2, and the aforementioned conditions, validated by substantial reasoning scores within the CTD. Additionally, we incorporated a &#x201c;negative control&#x201d; gene, PXDNL, an unrelated ORG, to bolster the conclusiveness of our analysis.</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Interactions between three key ORGs and the negative control gene PXDNL across various disease conditions. The analysis was conducted with the Comparative Toxicogenomics Database (CTD; <uri xlink:href="https://ctdbase.org/">http://ctdbase.org/</uri>). The inference scores between the three hub ORGs and <bold>(A)</bold> diabetic retinopathy, <bold>(B)</bold> retinal diseases, <bold>(C)</bold> eye diseases, <bold>(D)</bold> vascular diseases, <bold>(E)</bold> diabetes complications, and <bold>(F)</bold> diabetes mellitus are shown in bar plots.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1382896-g007.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>Proliferative diabetic retinopathy (PDR) poses a significant challenge in diabetes management and often leads to irreversible blindness. Current treatments such as panretinal photocoagulation have limitations, including potential adverse effects on visual acuity (<xref ref-type="bibr" rid="B29">29</xref>). Novel approaches such as CD40-TRAF6 inhibition (<xref ref-type="bibr" rid="B30">30</xref>) and anti-IL17A therapy (<xref ref-type="bibr" rid="B31">31</xref>) show promise in mouse models but require further clinical validation. These limitations underscore the pressing need for more effective and precise therapeutic strategies.</p>
<p>In our study, the integration of single-cell sequencing and Non-negative Matrix Factorization (NMF) was pivotal in revolutionizing our understanding of the transcriptional intricacies in PDR. This advanced methodological approach facilitated in-depth analysis of the disease transcriptional landscape, revealing the existence of specific gene modules and delineating three crucial meta-programs.</p>
<p>Our focused analysis, through the lens of NMF, allowed us to dissect the intricate patterns of gene expression, revealing how different gene modules interact and contribute to the pathophysiology of PDR. This nuanced understanding of gene modules and their interplay is critical, as it sheds light on the underlying mechanisms that drive the disease. In particular, the discovery of oxidative stress-related genes (ORGs), which are key players within these meta-programs, has been illuminating. This highlights the significant role that oxidative stress, a known factor in diabetic complications, plays in the progression of PDR.</p>
<p>In the context of oxidative stress and its implications for disease pathogenesis, the identification and study of ALKBH enzymes, particularly ALKBH8, have been pivotal. Previous research has elucidated the role of these enzymes in the intricate regulation of reactive oxygen species (ROS) production and oxidative stress, which are crucial processes in cellular homeostasis and disease development. For example, studies have highlighted the role of ALKBH8 in the development of human bladder cancer, where it contributes to the disease process by downregulating NAD(P)H oxidase-1 (NOX-1) and subsequently activating pathways such as the c-jun NH2-terminal kinase (JNK) and p38 pathways, which are involved in NADPH oxidase 1-dependent ROS production and apoptosis induction (<xref ref-type="bibr" rid="B32">32</xref>). Additionally, ALKBH8 has been implicated in the reduction of ROS production through similar mechanisms and in the regulation of selenocysteine protein expression, which serves as a defense against ROS damage in response to oxidative stress (<xref ref-type="bibr" rid="B33">33</xref>). These findings collectively underscore the substantial role of ALKBH, particularly ALKBH8, in the regulation of oxidative stress and its relevance to various disease processes.</p>
<p>Similarly, ATP13A2 has been extensively studied for its role in the regulation of cellular responses to oxidative stress. This gene is implicated in protective mechanisms against mitochondrial toxins such as rotenone, which is an environmental risk factor for Parkinson&#x2019;s disease (<xref ref-type="bibr" rid="B34">34</xref>). The function of ATP13A2 in mitigating oxidative stress is multifaceted. PSP not only aids in reducing levels of intracellular oxidative damage but also enhances the clearance of oxidatively damaged macromolecules (<xref ref-type="bibr" rid="B35">35</xref>). This finding suggested that ATP13A2 plays a significant protective role against oxidative stress, underscoring its importance in maintaining cellular health and preventing damage. Furthermore, the impaired function of ATP13A2 has been directly linked to increased oxidative stress in human neuroblastoma cells, highlighting its critical role in cellular defense mechanisms against oxidative damage (<xref ref-type="bibr" rid="B36">36</xref>).</p>
<p>These insights into ALKBH and ATP13A2 provide a deeper understanding of the molecular mechanisms by which oxidative stress influences disease progression and pathology. The significant relationship of these genes with the regulation of oxidative stress emphasizes their potential as therapeutic targets. In the context of PDR, where oxidative stress plays a central role, understanding these mechanisms is crucial. This approach opens potential avenues for targeted therapies that modulate oxidative stress pathways, potentially offering more effective treatment options for conditions such as PDR and beyond.</p>
<p>Therefore, elucidating the roles of ALKBH and ATP13A2 in oxidative stress regulation not only enhances our understanding of the cellular response to oxidative challenges but also positions these genes as key players in the development of novel therapeutic strategies for diseases where oxidative stress is a contributing factor.</p>
<p>Incorporating the AlphaFold 2 technology (<xref ref-type="bibr" rid="B22">22</xref>) into our research represents an innovation in our study. AlphaFold 2, an advanced protein structure prediction tool developed by DeepMind, has revolutionized the field of structural biology. Its ability to predict protein structures with unprecedented accuracy provides invaluable insights into the functional mechanisms of proteins at the molecular level.</p>
<p>In the context of our study on PDR, the application of AlphaFold 2 allowed us to predict the structures of key ORGs, namely, ALKBH1, PSIP1, and ATP13A2. This capability is crucial because it provides a deeper understanding of protein configurations and their potential interactions, which are often pivotal in determining their functional roles in cellular processes. The structural insights gained from AlphaFold 2 significantly augmented our understanding of protein&#x2212;protein interactions (PPIs) and the molecular pathways in which these ORGs are involved. The ability to visualize the precise structure of these proteins aids in elucidating their functional domains, interaction sites, and potential binding mechanisms, which are essential for elucidating their roles in the pathogenesis of PDR. Furthermore, the application of the AlphaFold 2 in our study sets a precedent for future research on diabetic retinopathy and other related diseases. By enabling a more accurate prediction of protein structures, new possibilities are available for the development of targeted therapeutic interventions, as structural insights are crucial for drug design and discovery.</p>
<p>Our findings resonate with and build upon existing related research in the field, such as the notable work of Hu et&#xa0;al., which focused on the involvement of microglia in PDR (<xref ref-type="bibr" rid="B12">12</xref>). This alignment with the findings of previous studies not only validates our findings but also adds a new dimension to our collective understanding of the disease. By contextualizing our results within the broader scientific narrative, we underscore the importance of oxidative stress in PDR pathogenesis and open potential avenues for targeted therapeutic interventions.</p>
<p>There are limitations to this study. While our bioinformatics approach has provided significant insights into potential key players in DR pathogenesis, we recognize that the identification of ALKBH, ATP13A2, and PSIP1 as potential biomarkers or therapeutic targets is preliminary and necessitates further experimental validation.</p>
<p>In conclusion, our study marks progress in molecular biology and disease research through the application of technologies such as AlphaFold 2, single-cell sequencing, machine learning and NMF. This methodological synergy has not only enriched our understanding of the molecular landscape of PDR but also highlighted the importance of ORGs in its pathogenesis. Our research underscores the value of harnessing advanced technologies to explore disease mechanisms and therapeutic innovations.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Materials</bold>
</xref>, further inquiries can be directed to the corresponding author/s.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>Ethical approval was not required for the study involving humans in accordance with the local legislation and institutional requirements. Written informed consent to participate in this study was not required from the participants or the participants&#x2019; legal guardians/next of kin in accordance with the national legislation and the institutional requirements.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>JW: Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. HS: Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. LM: Formal analysis, Writing &#x2013; original draft. YL: Formal analysis, Writing &#x2013; original draft. ZW: Formal analysis, Writing &#x2013; original draft. ZP: Conceptualization, Writing &#x2013; review &amp; editing. M-MY: Methodology, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported in part by the Shenzhen Science and Technology Program (No. JCYJ20220818102603007, GCZX2015043017281705) and the General Project of the Shenzhen Natural Science Foundation (No. JCYJ20210324113808023 and JCYJ20220530152813030).</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fendo.2024.1382896/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fendo.2024.1382896/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table_1.xlsx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
<supplementary-material xlink:href="Table_2.xlsx" id="SM2" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
<supplementary-material xlink:href="Table_3.xlsx" id="SM3" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
<supplementary-material xlink:href="Table_4.xlsx" id="SM4" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
<supplementary-material xlink:href="Table_5.xlsx" id="SM5" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
<supplementary-material xlink:href="Table_6.xlsx" id="SM6" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
<supplementary-material xlink:href="Table_7.xlsx" id="SM7" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
<supplementary-material xlink:href="Table_8.xlsx" id="SM8" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
<supplementary-material xlink:href="Table_9.xlsx" id="SM9" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
</sec>
<fn-group>
<title>Abbreviations</title>
<fn fn-type="abbr">
<p>PDR, Proliferative diabetic retinopathy; scRNA-seq, Single-cell RNA sequencing; NMF, Non-negative Matrix Factorization; ORGs, Oxidative stress-related genes; PPI, Protein-protein interaction; CTD, Comparative Toxicogenomics Database.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>H</given-names>
</name>
<name>
<surname>Niu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Rong</surname> <given-names>A</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Effect of adjunctive intravitreal conbercept injection at the end of 25G vitrectomy on severe proliferative diabetic retinopathy: 6-month outcomes of a randomised controlled trial</article-title>. <source>Ophthalmol Ther</source>. (<year>2023</year>) <volume>12</volume>:<page-range>1173&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s40123-023-00664-6</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Gonz&#xe1;lez-Cort&#xe9;s</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Gonzalez-Cantu</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Sudhalkar</surname> <given-names>A</given-names>
</name>
<name>
<surname>Hern&#xe1;ndez-Da Mota</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Bilgic</surname> <given-names>A</given-names>
</name>
<name>
<surname>Garza-Chavarria</surname> <given-names>JA</given-names>
</name>
<etal/>
</person-group>. <source>Treatment Algorithm in Proliferative Diabetic Retinopathy - From Protocols to the Real World</source>. (<publisher-loc>London, UNITED KINGDOM</publisher-loc>: <publisher-name>IntechOpen Limited</publisher-name>) (<year>2022</year>). doi:&#xa0;<pub-id pub-id-type="doi">10.5772/intechopen.99843</pub-id>.</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>She</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zou</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Differences in vitreous protein profiles in patients with proliferative diabetic retinopathy before and after ranibizumab treatment</article-title>. <source>Front Med</source>. (<year>2022</year>) <volume>9</volume>:<elocation-id>776855</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmed.2022.776855</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakao</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kaizu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Horie</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wada</surname> <given-names>I</given-names>
</name>
<name>
<surname>Arima</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fukuda</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Volumetric three-dimensional optical coherence tomography angiography of retinal neovascularization in proliferative diabetic retinopathy</article-title>. <source>Retinal cases Brief Rep</source>. (<year>2023</year>) <volume>17</volume>:<page-range>315&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/icb.0000000000001183</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pandit</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ho</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Yonekawa</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Recent advances in the management of proliferative diabetic retinopathy</article-title>. <source>Curr Opin Ophthalmol</source>. (<year>2023</year>) <volume>34</volume>:<page-range>232&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/icu.0000000000000946</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ju</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Experiment-based interventions to diabetic retinopathy: present and advances</article-title>. <source>Int J Mol Sci</source>. (<year>2022</year>) <volume>23</volume>:<elocation-id>7005</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms23137005</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kowluru</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Mohammad</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Mitochondrial fragmentation in a high homocysteine environment in diabetic retinopathy</article-title>. <source>Antioxidants</source>. (<year>2022</year>) <volume>11</volume>:<elocation-id>365</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/antiox11020365</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ozturk Kurt</surname> <given-names>HP</given-names>
</name>
<name>
<surname>Karag&#xf6;z</surname> <given-names>&#xd6;zenDS</given-names>
</name>
<name>
<surname>Gen&#xe7;</surname> <given-names>&#x130;</given-names>
</name>
<name>
<surname>Erdem</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Demira&#x11f;</surname> <given-names>MD</given-names>
</name>
</person-group>. <article-title>Comparison of selenium levels between diabetic patients with and without retinopathy</article-title>. <source>J Surg Med</source>. (<year>2023</year>) <volume>1</volume>:<page-range>58&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.28982/josam.7673</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Bang</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Single-cell RNA sequencing technologies and bioinformatics pipelines</article-title>. <source>Exp Mol Med</source>. (<year>2018</year>) <volume>50</volume>:<fpage>1</fpage>&#x2013;<lpage>14</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s12276-018-0071-8</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>G</given-names>
</name>
<name>
<surname>Ning</surname> <given-names>B</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Single-cell rna-seq technologies and related computational data analysis</article-title>. <source>Front Genet</source>. (<year>2019</year>) <volume>10</volume>:<elocation-id>317</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fgene.2019.00317</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papalexi</surname> <given-names>E</given-names>
</name>
<name>
<surname>Satija</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Single-cell RNA sequencing to explore immune cell heterogeneity</article-title>. <source>Nat Rev Immunol</source>. (<year>2018</year>) <volume>18</volume>:<fpage>35</fpage>&#x2013;<lpage>45</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri.2017.76</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Mao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>T</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Single-cell transcriptomics reveals novel role of microglia in fibrovascular membrane of proliferative diabetic retinopathy</article-title>. <source>Diabetes</source>. (<year>2022</year>) <volume>71</volume>:<page-range>762&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2337/db21-0551</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prelaj</surname> <given-names>A</given-names>
</name>
<name>
<surname>Miskovic</surname> <given-names>V</given-names>
</name>
<name>
<surname>Zanitti</surname> <given-names>M</given-names>
</name>
<name>
<surname>Trovo</surname> <given-names>F</given-names>
</name>
<name>
<surname>Genova</surname> <given-names>C</given-names>
</name>
<name>
<surname>Viscardi</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Artificial Intelligence for predictive biomarker discovery in immuno-oncology: a systematic review</article-title>. <source>Ann Oncol</source>. (<year>2023</year>) <volume>35</volume>:<page-range>29&#x2013;65</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.annonc.2023.10.125</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Addala</surname> <given-names>V</given-names>
</name>
<name>
<surname>Newell</surname> <given-names>F</given-names>
</name>
<name>
<surname>Pearson</surname> <given-names>JV</given-names>
</name>
<name>
<surname>Redwood</surname> <given-names>A</given-names>
</name>
<name>
<surname>Robinson</surname> <given-names>BW</given-names>
</name>
<name>
<surname>Creaney</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Computational immunogenomic approaches to predict response to cancer immunotherapies</article-title>. <source>Nat Rev Clin Oncol</source>. (<year>2023</year>) <volume>21</volume>:<page-range>28&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41571-023-00830-6</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cowan</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Renner</surname> <given-names>M</given-names>
</name>
<name>
<surname>De Gennaro</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gross-Scherf</surname> <given-names>B</given-names>
</name>
<name>
<surname>Goldblum</surname> <given-names>D</given-names>
</name>
<name>
<surname>Hou</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Cell types of the human retina and its organoids at single-cell resolution</article-title>. <source>Cell</source>. (<year>2020</year>) <volume>182</volume>:<fpage>1623</fpage>&#x2013;<lpage>1640.e34</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2020.08.013</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Becker</surname> <given-names>K</given-names>
</name>
<name>
<surname>Klein</surname> <given-names>H</given-names>
</name>
<name>
<surname>Simon</surname> <given-names>E</given-names>
</name>
<name>
<surname>Viollet</surname> <given-names>C</given-names>
</name>
<name>
<surname>Haslinger</surname> <given-names>C</given-names>
</name>
<name>
<surname>Leparc</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>In-depth transcriptomic analysis of human retina reveals molecular mechanisms underlying diabetic retinopathy   </article-title>. <source>Sci Rep</source>. (<year>2021</year>) <volume>11</volume>:<fpage>10494</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-021-88698-3</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>D</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zou</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Induced expression of VEGFC, ANGPT, and EFNB2 and their receptors characterizes neovascularization in proliferative diabetic retinopathy</article-title>. <source>Invest Ophthalmol Vis Sci</source>. (<year>2019</year>) <volume>60</volume>:<page-range>4084&#x2013;96</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1167/iovs.19-26767</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Hao</surname> <given-names>S</given-names>
</name>
<name>
<surname>Andersen-Nissen</surname> <given-names>E</given-names>
</name>
<name>
<surname>Mauck</surname> <given-names>WM</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>S</given-names>
</name>
<name>
<surname>Butler</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Integrated analysis of multimodal single-cell data</article-title>. <source>Cell</source>. (<year>2021</year>) <volume>184</volume>:<fpage>3573</fpage>&#x2013;<lpage>3587.e29</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2021.04.048</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laurens van der</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hinton</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Visualizing Data using t-SNE</article-title>. <source>Mach Learn Res</source>. (<year>2008</year>) <volume>9</volume>:<page-range>2579&#x2013;605</page-range>. Available at: <uri xlink:href="https://jmlr.org/papers/v9/vandermaaten08a.html">https://jmlr.org/papers/v9/vandermaaten08a.html</uri>.
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korsunsky</surname> <given-names>I</given-names>
</name>
<name>
<surname>Millard</surname> <given-names>N</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>J</given-names>
</name>
<name>
<surname>Slowikowski</surname> <given-names>K</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Fast, sensitive and accurate integration of single-cell data with Harmony</article-title>. <source>Nat Methods</source>. (<year>2019</year>) <volume>16</volume>:<page-range>1289&#x2013;96</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41592-019-0619-0</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kotliar</surname> <given-names>D</given-names>
</name>
<name>
<surname>Veres</surname> <given-names>A</given-names>
</name>
<name>
<surname>Nagy</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Tabrizi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hodis</surname> <given-names>E</given-names>
</name>
<name>
<surname>Melton</surname> <given-names>DA</given-names>
</name>
<etal/>
</person-group>. <article-title>Identifying gene expression programs of cell-type identity and cellular activity with single-cell RNA-Seq</article-title>. <source>Elife</source>. (<year>2019</year>) <volume>8</volume>:<elocation-id>e43803</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.7554/eLife.43803</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tunyasuvunakool</surname> <given-names>K</given-names>
</name>
<name>
<surname>Adler</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Green</surname> <given-names>T</given-names>
</name>
<name>
<surname>Zielinski</surname> <given-names>M</given-names>
</name>
<name>
<surname>&#x17d;&#xed;dek</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Highly accurate protein structure prediction for the human proteome</article-title>. <source>Nature</source>. (<year>2021</year>) <volume>596</volume>:<page-range>590&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41586-021-03828-1</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<collab>NCBI Resource Coordinators</collab>
<name>
<surname>Agarwala</surname> <given-names>R</given-names>
</name>
<name>
<surname>Barrett</surname> <given-names>T</given-names>
</name>
<name>
<surname>Beck</surname> <given-names>J</given-names>
</name>
<name>
<surname>Benson</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Bollin</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Database resources of the national center for biotechnology information</article-title>. <source>Nucleic Acids Res</source>. (<year>2018</year>) <volume>46</volume>:<fpage>D8</fpage>&#x2013;<lpage>D13</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkx1095</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname> <given-names>GM</given-names>
</name>
<name>
<surname>Huey</surname> <given-names>R</given-names>
</name>
<name>
<surname>Olson</surname> <given-names>AJ</given-names>
</name>
</person-group>. <article-title>Using AutoDock for ligand-receptor docking</article-title>. <source>Curr Protoc Bioinf</source>. (<year>2008</year>). doi:&#xa0;<pub-id pub-id-type="doi">10.1002/0471250953.bi0814s24</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Bryant</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>T</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gindulyte</surname> <given-names>A</given-names>
</name>
<name>
<surname>Shoemaker</surname> <given-names>BA</given-names>
</name>
<etal/>
</person-group>. <article-title>PubChem bioAssay: 2017 update</article-title>. <source>Nucleic Acids Res</source>. (<year>2017</year>) <volume>45</volume>:<page-range>D955&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkw1118</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>von Mering</surname> <given-names>C</given-names>
</name>
<name>
<surname>Huynen</surname> <given-names>M</given-names>
</name>
<name>
<surname>Jaeggi</surname> <given-names>D</given-names>
</name>
<name>
<surname>Schmidt</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bork</surname> <given-names>P</given-names>
</name>
<name>
<surname>Snel</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>STRING: a database of predicted functional associations between proteins</article-title>. <source>Nucleic Acids Res</source>. (<year>2003</year>) <volume>31</volume>:<page-range>258&#x2013;61</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkg034</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shannon</surname> <given-names>P</given-names>
</name>
<name>
<surname>Markiel</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ozier</surname> <given-names>O</given-names>
</name>
<name>
<surname>Baliga</surname> <given-names>NS</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>JT</given-names>
</name>
<name>
<surname>Ramage</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title>. <source>Genome Res</source>. (<year>2003</year>) <volume>13</volume>:<page-range>2498&#x2013;504</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davis</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Grondin</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Sciaky</surname> <given-names>D</given-names>
</name>
<name>
<surname>McMorran</surname> <given-names>R</given-names>
</name>
<name>
<surname>Wiegers</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>The comparative toxicogenomics database: update 2019</article-title>. <source>Nucleic Acids Res</source>. (<year>2019</year>) <volume>47</volume>:<page-range>D948&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gky868</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shahid</surname> <given-names>MH</given-names>
</name>
<name>
<surname>Rashid</surname> <given-names>F</given-names>
</name>
<name>
<surname>Tauqeer</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ali</surname> <given-names>R</given-names>
</name>
<name>
<surname>Farooq</surname> <given-names>M</given-names>
</name>
<name>
<surname>Aleem</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Change in central macular thickness on OCT after pan retinal photocoagulation</article-title>. <source>PJMHS</source>. (<year>2022</year>) <volume>16</volume>:<page-range>315&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.53350/pjmhs22166315</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howell</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Zapadka</surname> <given-names>TE</given-names>
</name>
<name>
<surname>Lindstrom</surname> <given-names>SI</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>BE</given-names>
</name>
<name>
<surname>R. Taylor</surname> <given-names>ZR</given-names>
</name>
<etal/>
</person-group>. <article-title>Inhibition of CD40-TRAF6-dependent inflammatory activity halts the onset of diabetic retinopathy in streptozotocin-diabetic mice</article-title>. <source>Nutr Diabetes</source>. (<year>2022</year>) <volume>12</volume>:<fpage>46</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41387-022-00225-z</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>AY</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>BE</given-names>
</name>
<name>
<surname>Barber</surname> <given-names>KG</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>CA</given-names>
</name>
<name>
<surname>R. Taylor</surname> <given-names>ZR</given-names>
</name>
<name>
<surname>Howell</surname> <given-names>SJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Anti-il17a halts the onset of diabetic retinopathy in type I and II diabetic mice</article-title>. <source>Int J Mol Sci</source>. (<year>2023</year>) <volume>24</volume>:<elocation-id>1347</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms24021347</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimada</surname> <given-names>K</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>M</given-names>
</name>
<name>
<surname>Anai</surname> <given-names>S</given-names>
</name>
<name>
<surname>De Velasco</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Tanaka</surname> <given-names>M</given-names>
</name>
<name>
<surname>Tsujikawa</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>A novel human AlkB homologue, ALKBH8, contributes to human bladder cancer progression</article-title>. <source>Cancer Res</source>. (<year>2009</year>) <volume>69</volume>:<page-range>3157&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/0008-5472.can-08-3530</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pil&#x17e;ys</surname> <given-names>T</given-names>
</name>
<name>
<surname>Marcinkowski</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kukwa</surname> <given-names>W</given-names>
</name>
<name>
<surname>Garbicz</surname> <given-names>D</given-names>
</name>
<name>
<surname>Dylewska</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ferenc</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>ALKBH overexpression in head and neck cancer: potential target for novel anticancer therapy</article-title>. <source>Sci Rep</source>. (<year>2019</year>) <volume>9</volume>:<fpage>13249</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-019-49550-x</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vrijsen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Besora-Casals</surname> <given-names>L</given-names>
</name>
<name>
<surname>van Veen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zielich</surname> <given-names>J</given-names>
</name>
<name>
<surname>den Haute</surname> <given-names>CV</given-names>
</name>
<name>
<surname>Hamouda</surname> <given-names>NN</given-names>
</name>
<etal/>
</person-group>. <article-title>ATP13A2-mediated endo-lysosomal polyamine export counters mitochondrial oxidative stress</article-title>. <source>Proc Natl Acad Sci</source>. (<year>2020</year>) <volume>117</volume>:<page-range>31198&#x2013;207</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1922342117</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Covy</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Waxman</surname> <given-names>EA</given-names>
</name>
</person-group>. <article-title>Characterization of cellular protective effects of ATP13A2/PARK9 expression and alterations resulting from pathogenic mutants</article-title>. <source>J Neurosci Res</source>. (<year>2012</year>) <volume>90</volume>:<page-range>2306&#x2013;16</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jnr.23112</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mukherjee</surname> <given-names>AB</given-names>
</name>
<name>
<surname>Appu</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Sadhukhan</surname> <given-names>T</given-names>
</name>
<name>
<surname>Casey</surname> <given-names>S</given-names>
</name>
<name>
<surname>Mondal</surname> <given-names>A</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses</article-title>. <source>Mol Neurodegeneration</source>. (<year>2019</year>) <volume>14</volume>:<fpage>4</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13024-018-0300-6</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>